Contract

BASF updates on Force Majeure: Nutritional ingredients not expected for some time

11-Jan-2018 By Nathan Gray

Global ingredients supplier BASF says it will be at least March before its citral plant in Germany is back on line - and up to three months longer until nutritional ingredients are commercially ready - after a fire prompted a ‘Force Majeure’ at the end...

MusclePharm settles Capstone suit, makes progress on restructuring

10-Nov-2016 By Hank Schultz

Struggling sports nutrition brand MusclePharm and its contract manufacturer Capstone Nutrition have settled a breach of contract suit.  Capstone reportedly settle for an $11 million payment from MusclePharm and dismissal of MusclePharm’s countersuit.

MusclePharm countersues, saying Capstone couldn't deliver products on time

29-Jun-2016 By Hank Schultz

Sports nutrition company MusclePharm has filed a countersuit in its dispute with contract manufacturer Capstone Nutrition. MusclePharm alleges Capstone was unable to manufacture products on time.

Capstone files $65 million breach of contract suit against MusclePharm

24-May-2016 By Hank Schultz

Capstone Nutrition has sued MusclePharm for breach of contract, stating in its complaint that “MusclePharm has essentially turned Capstone into its bank.”

Special edition: Contract manufacturing

Detailed quality agreements becoming vital part of contract manufacturing deals

19-May-2016 By Hank Schultz

Placing your trust in a contract manufacturing partner is a natural part of forming a business relationship. But underpinning that trust with solid contractual agreements is the key to maintaining quality, experts agree.

Neptune begins reconstruction of plant destroyed by fire

30-May-2013 By Hank Schultz

Neptune Technologies & Bioressources Inc. has begun the reconstruction of its production facility in Sherbrooke, Québec that was destroyed by fire on Nov. 8, 2012.

Valensa on astaxanthin dispute with Cyanotech: ‘It is disappointing it has come to this’

18-Jul-2012 By Elaine Watson

It is “disappointing” that two key players in the astaxanthin market have ended up talking via their attorneys after their “excellent business relationship” became frayed, Valensa International president Dr Rudi Moerck has admitted.

Pharmanutrients/Natural arbitration closed

20-Aug-2002

The American Arbitration Association has ruled that the disputed
agreement between PharmaNutrients and Norwegian company Natural,
created when the joint-venture separated in 1999, is 'valid and
enforceable.'

Forbes remains bullish despite Reducol failure

02-Apr-2002

Forbes Medi-Tech remains bullish about its prospects for the future
despite the failure of the Novartis-Quaker Oats joint venture which
was meant to promote a range of foods containing Reducol, the
cholesterol-cutting ingredient developed...